Table 4 Comparing interested outcomes risks between patients with SLE with and without vaccination stratified by age.
Age Group (years) | Nonvaccine cohort | Vaccine cohort | IRR | Adjusted HRb | (95% CI) | ||||
|---|---|---|---|---|---|---|---|---|---|
Variables | n (%) | Incidencea | n (%) | Incidencea | |||||
Total hospitalization | |||||||||
18–65 | 1786 | (22.11) | 25.71 | 296 | (21.07) | 23.95 | 0.93 | 0.87 | (0.77–0.98)* |
≥65 | 108 | (38.03) | 53.67 | 109 | (30.28) | 37.09 | 0.69 | 0.70 | (0.54–0.92)** |
Hospitalization for Pneumonia | |||||||||
18–65 | 147 | (1.82) | 1.85 | 27 | (1.92) | 1.95 | 1.05 | 0.88 | (0.47–1.33) |
≥65 | 27 | (9.51) | 10.99 | 20 | (5.56) | 5.84 | 0.53 | 0.46 | (0.25–0.83)* |
Hospitalization for septicemia, bacteremia, or viremia | |||||||||
18–65 | 137 | (1.70) | 1.72 | 14 | (1.00) | 1.01 | 0.59 | 0.49 | (0.28–0.86)* |
≥ 65 | 24 | (8.45) | 9.62 | 19 | (5.28) | 5.50 | 0.57 | 0.47 | (0.25–0.87)* |
Hospitalization for heart disease | |||||||||
18–65 | 434 | (5.37) | 5.59 | 97 | (6.90) | 7.20 | 1.02 | 1.02 | (0.82–1.28) |
≥65 | 46 | (16.20) | 19.37 | 53 | (14.72) | 16.26 | 0.84 | 0.76 | (0.50–1.13) |
ICU admission | |||||||||
18–65 | 171 | (2.12) | 2.15 | 23 | (1.64) | 1.66 | 0.77 | 0.63 | (0.40–0.98)* |
≥65 | 31 | (10.91) | 12.43 | 23 | (6.39) | 6.72 | 0.54 | 0.48 | (0.28–0.83)** |
In-hospital dialysis | |||||||||
18–65 | 66 | (0.82) | 0.83 | 5 | (0.36) | 0.36 | 0.43 | 0.40 | (0.20–0.81)* |
≥65 | 7 | (2.46) | 2.74 | 5 | (1.39) | 1.43 | 0.52 | 0.47 | (0.41–1.55) |
Death | |||||||||
18–65 | 97 | (1.20) | 1.21 | 11 | (0.78) | 0.79 | 0.65 | 0.52 | (0.28–0.97)* |
≥65 | 40 | (14.08) | 15.57 | 23 | (6.39) | 6.58 | 0.42 | 0.36 | (0.21–0.71)*** |
